“Big money” Positions

In 2018 Q4 Maximus Inc (NYSE:MMS) big money sentiment increased to 1.01, SEC.gov filings reveal. That’s up 0.12, from 2018Q3’s 0.89. 120 active investment managers opened new or increased positions, while 119 sold and trimmed stakes in Maximus Inc so the sentiment has improved. Funds own 58.55 million shares, up from 57.34 million shares in 2018Q3. Funds holding Maximus Inc in top 10 changed to 3 from 2 for an increase of 1. 23 Investors Sold All; 96 Reduced Holdings; 79 increased stakes while 41 active investment managers bought stakes.

Biggest Maximus Inc Shareholders

P2 Capital Partners Llc owns 946,665 shares in Maximus Inc as of 2018 Q4. As of 2018 Q4, 1.36 million shares of Maximus Inc are owned by Van Berkom & Associates Inc.. Ranger Investment Management L.P. reported 467,032 shares. The California-based fund Neumeier Poma Investment Counsel Llc have invested about 2.26% of the fund’s stock portfolio in Maximus Inc. The United Kingdom-based fund Mondrian Investment Partners Ltd holds 891,419 shares or 2.13% of their equity exposure.

MAXIMUS, Inc. provides business process services to government health and human services programs in the United States, the United Kingdom, Australia, Canada, and Saudi Arabia.The firm is worth $4.50 billion. The companyÂ’s Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Fit for Work Service.21.27 is the P/E ratio. The Company’s services include health insurance exchange customer contact center activities and support; health insurance program eligibility and enrollment; beneficiary outreach and education; application assistance and independent health plan enrollment counseling; premium payment processing and administration; health plan oversight; eHealth solutions with the Medigent product suite; independent disability, long-term sick, and health assessments; occupational health clinical assessments; and specialized program consulting services.

MMS hit $70.58 during the last trading session after $0.48 change.Currently MAXIMUS, Inc. is uptrending after 6.40% change in last April 9, 2018. MMS has also 58,291 shares volume. The stock outperformed the S&P500 by 2.03%.

MAXIMUS, Inc. (NYSE:MMS)’s earnings report is expected on May, 9., according to RTT. Analysts predict 12.20 % diference or $0.92 from the $0.82 EPS from 2018. If $0.92 is reported, MMS’s profit will hit $58.70 million for 19.18 P/E. Last quarter $0.86 earnings per share was reported. Analysts sees 6.98 % EPS growth this quarter.

8,618 were accumulated by Cim Ltd Liability Com. Retirement Of Alabama holds 83,154 shs or 0.03% of its capital. Teachers Retirement Sys Of The State Of Kentucky reported 12,256 shs. Private Advisor Gru Limited Com reported 7,577 shs stake. Georgia-based Invesco Ltd has invested 0.02% in MAXIMUS, Inc. (NYSE:MMS). Fmr Ltd holds 845,827 shs or 0.01% of its capital. Richard Bernstein Ltd Limited Liability Company holds 8,660 shs. Oregon Employees Retirement Fund invested in 0.02% or 1.66M shs. Northern Corporation has 1.10M shs. 928 are held by Huntington Fincl Bank. Wealthtrust stated it has 273 shs or 0.01% of all its holdings. Martingale Asset L P stated it has 0.1% of its capital in MAXIMUS, Inc. (NYSE:MMS). Cambiar Ltd owns 70,594 shs. Aqr Mgmt Ltd Company stated it has 912,443 shs. California State Teachers Retirement Systems invested in 100,004 shs or 0.01% of the stock.

MAXIMUS, Inc. registered $5.23 million net activity with 0 insider purchases and 5 sales since November 27, 2018. 6,715 shs were sold by LEDERER PAUL R, worth $470,290 on Tuesday, February 12. $2.16M worth of MAXIMUS, Inc. (NYSE:MMS) was sold by MONTONI RICHARD A. $64,140 worth of MAXIMUS, Inc. (NYSE:MMS) was sold by BELIVEAU RUSSELL A.

More recent MAXIMUS, Inc. (NYSE:MMS) news were published by Seekingalpha.com, Seekingalpha.com and Globenewswire.com. The first one has “Medical Devices Stock Price Gain Opportunity: Edwards Lifesciences – Seeking Alpha” as a title and was published on March 12, 2019. The next is “China Mobile: The Defensive 5G Play – Seeking Alpha” on April 09, 2019. And last was published on March 26, 2019, called “Detailed Research: Economic Perspectives on Biogen, Invesco, Bunge, Concho Resources, Maximus, and Meredith — What Drives Growth in Today’s Competitive Landscape – GlobeNewswire”.